SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1163)5/5/2002 2:36:41 PM
From: nigel bates  Read Replies (1) of 2243
 
f I were going to go with a technology, I'd go with CAT....I give the partner "nod" to ABGX

Might not the HGSI/CAT deal prove to be a pretty decent one as well, even if not quite on the scale of CRGN/ABGX ?
(I bought some CRGN last week).
On the 'technology' front, it seems to have been quite a while since the mAb companies started boasting about getting from target to IND in 12 months, but there haven't been all that many new mAbs announced.
Given that the first mAbs resulting from the deals in 1999/2000 are just now beginning to hit the clinic, and bearing in mind the huge number of new targets have been talked about, the next six months or so should be very instructive.

btw, put together a 'timeline' for MEDX which might be useful for reference.
Message 17418846

nig
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext